For individuals acquiring other opioid analgesics and switching to this drug or for the prolonged-release formulations of this drug, it is safer to undervalue a affected individual's 24-hour oral need and supply rescue medication than overestimate and control an adverse response; there is considerable inter-affected individual variation from the re